Citations

Clear

439 citation(s) found for "Stone, M".

Breaking tolerance with engineered class I antigen-presenting molecules
Parks, Christopher A. , Henning, Kalli R., Hansen, Michael J. , Keulen, Virginia P. Van , Reed, Brendan , Schrum, Adam G. , Gil, Diana , Kranz, David M. , Bordner, Andrew J., Barry, Michael A. , Pease, Larry R. , Pavelko, Kevin D. , Reed, Brendan K, Schrum, Adam G , Barry, Michael A , Stone, Jennifer D.

Mayo Clinic

Proceedings of the National Academy of Sciences | April 1, 2019 | Volume: 116 | Issue: 8 | Pages: 3136-3145

10.1073/pnas.1807465116 | PMID 30728302 Get It

Significance Provision of sufficient activating signals can drive self-tolerant T cells to cross-react on self-peptide-MHC in a breakdown of tolerance. This approach has been applied in the development of heteroclitic peptide vaccines, which retain sufficient similarity to self to allow reactivation of effector cells on unaltered self-epitopes but require detailed knowledge about the behavior of individual altered self-peptide antigens. We designed altered-self MHC mutant antigen-presenting molecules to drive CTL capable of cross-reacting on self-peptide-MHC and demonstrate the breaking of self-tolerance to defined and undefined self-antigens. These findings bear particular importance in the field of cancer immunotherapy in which breaking tolerance to weakly antigenic cancer-associated antigens is fundamental to vaccination strategies.
190. DETECTION OF CIRCULATING PR3-SPECIFIC B CELLS IN PATIENTS WITH ACTIVE ANCA-ASSOCIATED VASCULITIS
Cornec, Divi, Hummel, Amber M., Peikert, Tobias, Langford, Carol A. , Clair, E. William St. , Harris, Kristina M. , Stone, John H., Abdullahad, Wayel, Specks, U., Cornec, Divi , Berti, Alvise , Carmona, Eva M. , Monach, Paul A. , Merkel, Peter A. , Seo, Philip , Spiera, Robert , Fervenza, Fernando C. , Pers, Jacques-Olivier , Heeringa, Peter , Specks, Ulrich

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez061.004 Get It

053. CLINICAL UTILITY OF SERIAL MEASUREMENTS OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODIES TARGETING PROTEINASE 3 IN ANCA-ASSOCIATED VASCULITIS
Thompson, Gwen , Fussner, Lynn A. , Hummel, Amber M., Snyder, Melissa, Kallenberg, Cees G. M., Langford, Carol A. , Clair, E. William St. , Stone, John H. , Schroeder, Darrell R. , Silva, Francisco , Snyder, Melissa, Merkel, Peter A. , Monach, Paul A. , Seo, Philip , Spiera, Robert , Specks, Ulrich

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez057.052 Get It

222. PREFERENTIAL BINDING TO AN UNEXPECTED EPITOPE OF A CHIMERIC RECOMBINANT PROTEINASE 3 VARIANT BY ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODIES
Thompson, Gwen , Nelson, Darlene R. , Fussner, Lynn A. , Hummel, Amber M., Jenne, Dieter E. , Hoffman, Gary J., Kallenberg, Cees G. M., Langford, Carol A. , McCune, Joseph W., Clair, E. William St. , Ytterberg, Steven R. , Stone, John , Moura, Marta Casal , Fervenza, Fernando C. , Hoffman, Gary, Merkel, Peter A. , Monach, Paul A. , Seo, Philip , Spiera, Robert , Stone, John, Robinson, William H. , Pang, Yuan‐Ping , Specks, Ulrich

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez061.037 Get It

172. THE ASSOCIATION OF DIFFERENCES IN LIPID PARAMETERS WITH DISEASE ACTIVITY IN ANCA-ASSOCIATED VASCULITIS (AAV)
Wallace, Zachary S. , Fu, Serena, Kallenberg, Cees G. M., Langford, Carol A. , Clair, E. William St. , Stone, John H. , Liao, Katherine P. , Zhang, Yuqing , Merkel, Peter A. , Seo, Philip , Specks, Ulrich , Spiera, Robert , Choi, Hyon K.

Mayo Clinic

Rheumatology | March 29, 2019 | Volume: 58 | Issue: Supplement_2 | Pages: No page available

10.1093/rheumatology/kez059.049 Get It

Oligoclonal bands increase the specificity of MRI criteria to predict multiple sclerosis in children with radiologically isolated syndrome
Makhani, Naila , Sıva, Aksel , Narula, Sona , Wassmer, Evangeline , Brassat, David, Brenton, J. Nicholas , Cabre, Philippe, Carra‐Dallière, Clarisse , Dubief, Françoise Durand, Inglese, Matilde , Langille, Megan, Mathey, Guillaume , Pelletier, Jean , Reich, Daniel S. , Rojas, Juan Ignacio , Shabanova, Veronika , Shapiro, Eugene D. , Stone, Robert T, Tenembaum, Sílvia , Tintoré, Mar , Uygunoğlu, Uğur , Vargas, Wendy , Venkateswaren, Sunita, Kantarci, Orhun H. , Pelletier, Daniel , Durand‐Dubief, Françoise , Carra Dallière, Clarisse , Reich, Daniel S , Tintoré, Mar , Brenton, J Nicholas , Siva, Aksel , Lebrun‐Frénay, Christine , Seze, Jerome De , Neuteboom, Rinze Frederik , Pohl, Daniela , Stone, Robert Thompson, Vermersch, Patrick , Okuda, Darin T. , Wassmer, Evangeline , Durand-Dubief, Françoise

Mayo Clinic

Multiple Sclerosis Journal - Experimental, Translational and Clinical | March 21, 2019 | Volume: 5 | Issue: 1 | Pages: No page available

10.1177/2055217319836664 | PMID 30915227 Get It

Background Steps towards the development of diagnostic criteria are needed for children with the radiologically isolated syndrome to identify children at risk of clinical demyelination. Objectives To evaluate the 2005 and 2016 MAGNIMS magnetic resonance imaging criteria for dissemination in space for multiple sclerosis, both alone and with oligoclonal bands in cerebrospinal fluid added, as predictors of a first clinical event consistent with central nervous system demyelination in children with radiologically isolated syndrome. Methods We analysed an international historical cohort of 61 children with radiologically isolated syndrome (≤18 years), defined using the 2010 magnetic resonance imaging dissemination in space criteria (Ped-RIS) who were followed longitudinally (mean 4.2 ± 4.7 years). All index scans also met the 2017 magnetic resonance imaging dissemination in space criteria. Results Diagnostic indices (95% confidence intervals) for the 2005 dissemination in space criteria, with and without oligoclonal bands, were: sensitivity 66.7% (38.4–88.2%) versus 72.7% (49.8–89.3%); specificity 83.3% (58.6–96.4%) versus 53.9% (37.2–69.9%). For the 2016 MAGNIMS dissemination in space criteria diagnostic indices were: sensitivity 76.5% (50.1–93.2%) versus 100% (84.6–100%); specificity 72.7% (49.8–89.3%) versus 25.6% (13.0–42.1%). Conclusions Oligoclonal bands increased the specificity of magnetic resonance imaging criteria in children with Ped-RIS. Clinicians should consider testing cerebrospinal fluid to improve diagnostic certainty. There is rationale to include cerebrospinal fluid analysis for biomarkers including oligoclonal bands in planned prospective studies to develop optimal diagnostic criteria for radiologically isolated syndrome in children.
Go for the Gold: A “Plane” and Simple Technique for Resecting Benign Peripheral Nerve Sheath Tumors
Stone, Jonathan J. , Spinner, Robert J.

Mayo Clinic

Operative Neurosurgery | March 19, 2019 | Volume: 18 | Issue: 1 | Pages: 60-68

10.1093/ons/opz034 | PMID 30888029 Get It

Abstract BACKGROUND Intraneural dissection is a useful technique for achieving gross total resection and preserving functional fascicles for peripheral nerve tumors. Finding the correct tissue plane is the critical step for safe successful enucleation. The authors hypothesized that the yellow color of benign nerve tumors can be used to identify surgical planes. OBJECTIVE To describe a technique to find the correct intraneural dissection plane based on a quantified yellow appearance during resection of benign peripheral nerve sheath tumors. METHODS Intraoperative photographs were reviewed to determine the percentage of yellow that tumors appeared at different phases of surgery. A technique was developed to quantitatively measure the amount of yellow using Photoshop. Previously published journal articles containing color images of peripheral nerve tumor resections were also analyzed for yellow tumor color. RESULTS There were 24 patients with suitable images to permit measurement of color for 3 steps of the procedure. The average percentages of yellow for tumor exposure, tumor resection, and removed specimen were 36.5%, 59.1%, and 80.4%, respectively ( P < .001). Three publications were found that contained high-quality images of at least 2 phases of the surgery with average yellow content of 47.4% and 84% ( P < .01). CONCLUSION The simple observation that a benign nerve sheath tumor is yellow in color can be used to guide surgical resection and achieve excellent outcomes. Intraneural dissection through the pseudocapsule should be pursued layer by layer until a yellow true capsule is found. By sparing functional nervous tissue within the pseudocapsule, this technique may lead to improved neurological outcomes.
Inflammatory Bowel Disease in Pregnancy Clinical Care Pathway: A Report From the American Gastroenterological Association IBD Parenthood Project Working Group
Mahadevan, Uma , Bernasko, Nana, Boland, Brigid S. , Dubinsky, Marla C. , Friedman, Sonia , Kane, Sunanda V. , Manthey, Jacob, Sauberan, Jason , Robinson, Christopher James , Chambers, Christina , Stone, James L. , Jain, Rajeev Kumar , Friedman, Sonia

Mayo Clinic

Inflammatory Bowel Diseases | March 1, 2019 | Volume: 25 | Issue: 4 | Pages: 627-641

10.1093/ibd/izz037 | PMID 30821832 Get It

Predictors of mortality in patients with non‐anterior ST‐segment elevation myocardial infarction: Analysis from the HORIZONS‐AMI trial
Huang, Xin , Redfors, Björn , Mehran, Roxana , Zhang, Yiran , McAndrew, Thomas , Ben‐Yehuda, Ori , Mintz, Gary S. , Stone, Gregg W. , Mehran, Roxana , Chen, Shmuel , Gersh, Bernard J.

Mayo Clinic

Catheterization and Cardiovascular Interventions | January 28, 2019 | Volume: 94 | Issue: 2 | Pages: 172-180

10.1002/ccd.28096 | PMID 30690854 Get It

Abstract Objectives We sought to identify clinical, electrocardiographic (ECG), and angiographic characteristics that are predictive of 3‐year mortality after primary percutaneous coronary intervention (PCI) in patients with non‐anterior ST‐elevation myocardial infarction (NA‐STEMI) from the Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS‐AMI) trial. Background Which patients with NA‐STEMI undergoing PCI have a poor prognosis is uncertain. Methods NA‐STEMI was defined as ST‐segment elevation in lateral (V5, V6, I, aVL), inferior (II, III, aVF), or inferolateral (I, II, III, aVF, and V5‐V6) ECG leads or posterior myocardial infarction with ST‐segment depression of ≥1 mm in ≥2 contiguous anterior leads. Cox regression was used to identify independent predictors of 3‐year mortality. Missing data were imputed using multiple imputation. Results In HORIZONS‐AMI, 2,578/3,602 patients had no prior coronary artery bypass grafting, underwent single‐vessel PCI, and had baseline ECG data assessed in an independent core laboratory. Among them, 1,495 (58.0%) had NA‐STEMI. Patients with NA‐STEMI had lower 3‐year mortality risk than those with anterior STEMI (4.5% versus 7.1%, P = 0.004). The independent predictors of increased 3‐year mortality in NA‐STEMI were older age (median > 59.0 years), diabetes, reduced LVEF (≤50%), Killip class ≥2, post‐procedure TIMI flow 0–2 versus 3, renal insufficiency, and ST‐resolution <30% at 60 min post‐PCI. Patients with 0, 1, 2, 3, and ≥4 of these risk factors had 3‐year mortality rates of 1.8%, 2.3%, 3.1%, 6.1%, and 36.3%, respectively ( P < 0.0001). Conclusions Although NA‐STEMI carries a better prognosis than anterior STEMI, high‐risk patient cohorts with NA‐STEMI may be identified who have substantial 3‐year mortality.